Niagen Bioscience (NAGE) stock
Pro members see every stock ranked and every check behind each score, live.
NAGE's Quality Score rose 2 points on Fri, Oct 2, to 4.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live. So can you, free, with no account.
Why NAGE is down
Niagen Bioscience fell 8.2% on Oct 1; it filed no 8-K that day, and its industry fell a median 2.7%.
Biotech stocks fell a median 2.7% and the S&P 500 rose 0.2% that day; Niagen Bioscience fell 8.2%.
−2Long-term trend below a falling 200-day average, down over one year
1 more driver and the timeline, for Pro members
1 more thing pulling NAGE's score down, for Pro members
What's next
Expected to report Tue Nov 3, after the close
After its last 4 reports it closed -7.0% on average, higher 1 of 4 times.
What would turn NAGE's score around: 6 things, for Pro members
Here is what Pro members see.
See it live, free until Tuesday morning. No account. No card. Then keep going with a free account. Every stock ranked for you.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
NAGE has 5 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1435.9
- MACD (12, 26, 9)Below signal
- 50-day average$3.11
- 200-day average$4.31
- ADX 1417.0
- Resistance$3.12
- Bollinger Bands (20, 2)Inside
- Volume3.6x
How NAGE ranks in Biotech
NAGE is #75 of 300 by Quality Score. The top three are shown with their scores, and more by name.
KNSA7/1418
EXEL7/1417
AMRX6/1417
MPLTOpen for its score
MRNAOpen for its score
NAMSOpen for its score
NBIXOpen for its score
NAGE5/144
When does NAGE report earnings, and what happens after?
Expected to report Tue Nov 3, after the close (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 4, 2026After close | After close | -10.4% | -14.7% | -11.2% |
| May 6, 2026After close | After close | -12.3% | -15.7% | -24.4% |
| Mar 4, 2026After close | After close | +15.2% | +3.2% | -1.0% |
| Nov 4, 2025After close | After close | +8.6% | -1.0% | +3.0% |
About Niagen Bioscience
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of NAGE's score, with the points and the reason
- All 14 checks on NAGE and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on NAGE
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.